Intelligent Bio Solutions Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1M | $1.1M | $896.8K | $1.1M | $410.8K | $902.1K | $741.1K | $998.4K |
| Cost of Revenue | $609.2K | $525.4K | $437.0K | $593.5K | $508.3K | $387.5K | $384.4K | $525.5K |
| Gross Profit | $536.6K | $535.4K | $459.7K | $518.3K | $335.6K | $341.4K | $223.1K | $346.8K |
| Gross Margin | 46.8% | 50.5% | 51.3% | 46.6% | 81.7% | 37.8% | 30.1% | 34.7% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.0M | $2.5M | $2.3M | $2.7M | $2.7M | $2.4M | $1.8M | $1.9M |
| Operating Income | $-4.0M | $-2.9M | $-2.6M | $-3.0M | $-3.1M | $-2.6M | $-2.3M | $-2.7M |
| Operating Margin | -351.3% | -277.8% | -293.9% | -269.8% | -761.6% | -283.8% | -305.5% | -273.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-3.9M | $-2.9M | $-2.7M | $-3.0M | $-3.1M | $-2.5M | $-2.2M | $-2.7M |
| Net Margin | -341.0% | -269.9% | -298.6% | -268.3% | -752.1% | -281.9% | -303.5% | -269.0% |
| EPS (Basic) | $-3.47 | $-0.60 | $-0.94 | $-0.12 | $-9.97 | $-1.47 | $-1.65 | $-0.23 |
| EPS (Diluted) | $-3.47 | $-0.60 | $-0.94 | $-0.12 | $-9.97 | $-1.47 | $-1.65 | $-0.23 |
| Shares Outstanding (Basic) | 1.5M | 4.8M | 2.9M | 25.6M | 527.4K | 1.7M | 1.4M | 11.4M |
| Shares Outstanding (Diluted) | 1.5M | 4.8M | 2.9M | 25.6M | 527.4K | 1.7M | 1.4M | 11.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |